JY
AKCA

Jeff Yass’s Akcea Therapeutics Inc AKCA Stock Holding History

Jeff Yass’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-11,400
Closed -$207K – 12120
2020
Q3 		$207K Sell
11,400
-9,100
-44% -$129K ﹤0.01% 9397
2020
Q2 		$281K Sell
20,500
-17,400
-46% -$268K ﹤0.01% 8466
2020
Q1 		$542K Sell
37,900
-22,900
-38% -$376K ﹤0.01% 6764
2019
Q4 		$1.03M Sell
60,800
-36,300
-37% -$675K ﹤0.01% 5465
2019
Q3 		$1.49M Buy
97,100
+28,100
+41% +$599K ﹤0.01% 4828
2019
Q2 		$1.62M Sell
69,000
-37,700
-35% -$931K ﹤0.01% 4597
2019
Q1 		$3.02M Sell
106,700
-5,100
-5% -$149K ﹤0.01% 3113
2018
Q4 		$3.37M Sell
111,800
-16,900
-13% -$474K ﹤0.01% 2774
2018
Q3 		$4.51M Buy
128,700
+100,700
+360% +$3.05M ﹤0.01% 2816
2018
Q2 		$664K Buy
28,000
+2,700
+11% +$64.5K ﹤0.01% 6237
2018
Q1 		$648K Buy
+25,300
New +$545K ﹤0.01% 6124

Jeff Yass's AKCA Position: Q2 2020 in Review

Jeff Yass sold out of Akcea Therapeutics Inc (AKCA) in Q2 2020, closing a stake of 33,430 shares — an estimated $516K sold.

Jeff Yass first reported a position in AKCA in Q2 2019 and held it in 3 quarters. The position peaked at $1.03M in Q4 2019. 84 funds tracked by Wall St. Rank hold AKCA as of Q2 2020.

  • Jeff Yass reported no remaining Akcea Therapeutics Inc position as of Q2 2020 after selling out during the quarter.
  • Jeff Yass sold 33,430 Akcea Therapeutics Inc shares in Q2 2020, an estimated $516K.
  • Jeff Yass first reported a position in Akcea Therapeutics Inc in Q2 2019 and held it in 3 quarters.
  • Jeff Yass's Akcea Therapeutics Inc position peaked at $1.03M in Q4 2019.
  • 84 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q2 2020.

Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.